20851-2 |
Bovine herpesvirus 5 Ag |
PrThr |
Tiss |
Pt |
Ord |
IF |
|
ACTIVE |
Bovine herpesvirus 5 Ag [Presence] in Tissue by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20851-2 |
|
IF |
|
|
Both |
|
|
|
0 |
BoHV5 Ag Tiss Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Beef; BoHV; BoHV5; DFA; FA; Fluorescent antibody; Fluoresent; Herpes virus; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20852-0 |
Duck enteritis virus Ag |
PrThr |
Tiss |
Pt |
Ord |
IF |
|
ACTIVE |
Duck enteritis virus Ag [Presence] in Tissue by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20852-0 |
|
IF |
|
|
Both |
|
|
|
0 |
DVE Ag Tiss Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; Duck plague; Duck virus enteritis; DVE; FA; Fluorescent antibody; Fluoresent; Herpesvirus; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20853-8 |
Equine herpesvirus 1 Ag |
PrThr |
Tracheal swab |
Pt |
Ord |
IF |
|
ACTIVE |
Equine herpesvirus 1 Ag [Presence] in Tracheal swab by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20853-8 |
|
IF |
|
|
Both |
|
|
|
0 |
EHV1 Ag Tracheal Swb Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; EHV; EHV1; EHV-1; Equid; Equid alphaherpesvirus 1; Equin; Equine abortion herpesvirus; Equine rhinopneumonitis; FA; Fluorescent antibody; Fluoresent; Herpes virus; i; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tracheal Swb; TRF; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20854-6 |
Equine herpesvirus 1 Ag |
PrThr |
Tiss |
Pt |
Ord |
IF |
|
ACTIVE |
Equine herpesvirus 1 Ag [Presence] in Tissue by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20854-6 |
|
IF |
|
|
Both |
|
|
|
0 |
EHV1 Ag Tiss Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; EHV; EHV1; EHV-1; Equid; Equid alphaherpesvirus 1; Equin; Equine abortion herpesvirus; Equine rhinopneumonitis; FA; Fluorescent antibody; Fluoresent; Herpes virus; i; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20855-3 |
IgG.bovine |
MCnc |
Ser |
Pt |
Qn |
Immune diffusion |
|
ACTIVE |
IgG.bovine [Mass/volume] in Serum by Immune diffusion (ID) |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
20855-3 |
|
Immune diffusion |
|
|
Both |
|
|
|
0 |
IgG Bovine Ser ID-mCnc |
|
|
|
Y |
|
Beef; Chemistry; ID; IgG Bovine; Imm; Immune globulin G; Immunodiff; Immunodiffusion; Immunoglobulin G; Imun; Imune; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.42 |
1.0m |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
20856-1 |
IgG.equine |
MCnc |
Body Fld^Fetus |
Pt |
Qn |
Immune diffusion |
|
ACTIVE |
IgG.equine [Mass/volume] in Body fluid from Fetus by Immune diffusion (ID) |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
20856-1 |
|
Immune diffusion |
|
|
Both |
|
|
|
0 |
IgG Equine Fld Fetus ID-mCnc |
|
|
|
Y |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Equin; Fetal; Fl; Fld; FLU; Fluid; ID; IgG Equine; Imm; Immune globulin G; Immunodiff; Immunodiffusion; Immunoglobulin G; Imun; Imune; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Vet; Veterinary |
2.67 |
1.0m |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
20857-9 |
IgG.equine |
MCnc |
Col |
Pt |
Qn |
Immune diffusion |
|
ACTIVE |
IgG.equine [Mass/volume] in Colostrum by Immune diffusion (ID) |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
20857-9 |
|
Immune diffusion |
|
|
Both |
|
|
|
0 |
IgG Equine Col ID-mCnc |
|
|
|
Y |
|
Chemistry; Colostrum; Equin; ID; IgG Equine; Imm; Immune globulin G; Immunodiff; Immunodiffusion; Immunoglobulin G; Imun; Imune; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.42 |
1.0m |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
20858-7 |
Infectious bronchitis virus genotype |
Prid |
Isolate |
Pt |
Nom |
PAGE |
|
ACTIVE |
Infectious bronchitis virus genotype [Identifier] in Isolate by Polyacrylamide gel electrophoresis (PAGE) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20858-7 |
|
PAGE |
|
|
Both |
|
|
|
0 |
IBV Gentyp Islt PAGE |
|
|
|
|
|
Avian infectious bronchitis; Gentyp; IBV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Polyacrylamide gel electrophoresis; Random; Vet; Veterinary |
2.72 |
1.0m |
|
|
|
|
|
|
|
|
|
|
|
0 |
20859-5 |
Infectious bronchitis virus serotype |
Prid |
Isolate |
Pt |
Nom |
Neut |
|
ACTIVE |
Infectious bronchitis virus serotype [Identifier] in Isolate by Neutralization test |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20859-5 |
|
Neut |
|
|
Both |
|
|
|
0 |
IBV Sertyp Islt Nt |
|
|
|
|
|
Avian infectious bronchitis; Conventional virus neutralization test; cVNT; IBV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; NEUTRALIZATION; Neutralization test; Nominal; NT; Point in time; Random; Sertyp; Serum virus neutralization; SVN; Vet; Veterinary; Virus neutralization test; VNT |
2.19 |
1.0m |
|
|
|
|
|
|
|
|
|
|
|
0 |
2086-7 |
Cholesterol.in HDL |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Cholesterol.in HDL [Mass/volume] in Serum or Plasma |
|
DEL |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
2086-7 |
|
|
|
|
|
|
|
|
0 |
Deprecated HDLc SerPl-mCnc |
|
|
|
|
|
Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; HDLc; HDL-C; High density lipoprotein cholesterols; Level; Lipid; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TCHHDL |
2.36 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
20860-3 |
Infectious bronchitis virus |
PrThr |
Tiss |
Pt |
Ord |
Organism specific culture |
|
ACTIVE |
Infectious bronchitis virus [Presence] in Tissue by Organism specific culture |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20860-3 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
IBV Tiss Ql Cult |
|
|
|
|
|
Avian infectious bronchitis; C&S; Cult; Cultures; IBV; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Tissue; Tissue, unspecified; Vet; Veterinary |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20861-1 |
Infectious bronchitis virus genotype |
Prid |
Isolate |
Pt |
Nom |
Probe.amp.tar |
|
ACTIVE |
Infectious bronchitis virus genotype [Identifier] in Isolate by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20861-1 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
IBV Gentyp Islt NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian infectious bronchitis; DNA NUCLEIC ACID PROBE; DNA probe; Gentyp; IBV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vet; Veterinary |
2.72 |
1.0m |
|
|
|
|
|
|
|
|
|
|
|
0 |
20862-9 |
Influenza virus A Ab |
PrThr |
Ser |
Pt |
Ord |
HAI |
|
ACTIVE |
Influenza virus A Ab [Presence] in Serum by Hemagglutination inhibition |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20862-9 |
|
HAI |
|
|
Both |
|
|
|
0 |
FLUAV Ab Ser Ql HAI |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian influenza; Bird flu; FLUA; FLUAV; FLUV; Fowl plague; Hemagglutination inhibition; HI; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20863-7 |
Iodine |
MCnc |
Water |
Pt |
Qn |
|
|
ACTIVE |
Iodine [Mass/volume] in Water |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
20863-7 |
|
|
|
|
Observation |
|
|
|
0 |
Iodine Wat-mCnc |
|
|
|
Y |
|
c616; DRUG/TOXICOLOGY; Drugs; i; I-; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Wat |
2.34 |
1.0m |
|
|
|
|
|
|
|
|
|
|
|
0 |
20864-5 |
Iodine |
MCnc |
Milk |
Pt |
Qn |
|
|
ACTIVE |
Iodine [Mass/volume] in Milk |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20864-5 |
|
|
|
|
Both |
|
|
|
0 |
Iodine Mlk-mCnc |
|
|
|
Y |
|
c616; DRUG/TOXICOLOGY; Drugs; i; I-; Level; Mass concentration; Mlk; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.42 |
1.0m |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
20865-2 |
Iodine |
MCnt |
Liver |
Pt |
Qn |
|
|
ACTIVE |
Iodine [Mass/mass] in Liver |
|
MIN |
DefinitionDescription |
|
|
ug/g |
|
|
|
|
|
|
DRUG/TOX |
|
20865-2 |
|
|
|
|
Both |
|
|
|
0 |
Iodine Liver-mCnt |
|
|
|
Y |
|
c616; DRUG/TOXICOLOGY; Drugs; Hepar; Hepatic; i; I-; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.42 |
1.0m |
|
|
|
|
|
|
|
ug/g |
|
|
|
0 |
20866-0 |
Lactobacillus acidophilus colony count |
NCnc |
Milk |
Pt |
Qn |
Organism specific culture |
|
ACTIVE |
Lactobacillus acidophilus colony count [#/volume] in Milk by Organism specific culture |
|
MIN |
DefinitionDescription |
|
|
/mL |
|
|
|
|
|
|
MICRO |
|
20866-0 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
L acidophilus CC # Mlk Cult |
|
|
|
Y |
|
#; ABS; absolute; absolutes; C&S; CC; Cnt; Colonies; Count; Count/volume; CT; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; L acidophilus CC; Microbiology; Mlk; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spec |
2.42 |
1.0m |
|
|
|
|
|
|
|
/mL |
|
|
|
0 |
20867-8 |
Lead |
MCnt |
Bone |
Pt |
Qn |
|
|
ACTIVE |
Lead [Mass/mass] in Bone |
|
MIN |
DefinitionDescription |
|
|
ug/g |
|
|
|
|
|
|
DRUG/TOX |
|
20867-8 |
|
|
|
|
Both |
|
|
|
0 |
Lead Bone-mCnt |
|
|
|
Y |
|
BON; DRUG/TOXICOLOGY; Drugs; Mass content; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.4 |
1.0m |
|
|
|
|
|
|
|
ug/g |
|
|
|
0 |
20868-6 |
Leptospira sp |
PrThr |
Tiss |
Pt |
Ord |
IF |
|
ACTIVE |
Leptospira sp [Presence] in Tissue by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20868-6 |
|
IF |
|
|
Both |
|
|
|
0 |
Leptospira Tiss Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Leptospirosis; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20869-4 |
Leptospira sp |
PrThr |
Tiss |
Pt |
Ord |
Organism specific culture |
|
ACTIVE |
Leptospira sp [Presence] in Tissue by Organism specific culture |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20869-4 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
Leptospira Tiss Ql Cult |
|
|
|
|
|
C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Leptospirosis; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; species; spp; Tissue; Tissue, unspecified |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
2087-5 |
Cholesterol.in IDL |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cholesterol in IDL [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
2087-5 |
|
|
|
|
Observation |
|
|
|
0 |
IDLc SerPl-mCnc |
|
|
|
Y |
|
Beta VLDL; Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; IDLc; Intermediate density lipoprotein cholesterols; Level; Lipid; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
20870-2 |
Listeria sp |
PrThr |
Milk |
Pt |
Ord |
Organism specific culture |
|
ACTIVE |
Listeria sp [Presence] in Milk by Organism specific culture |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20870-2 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
Listeria Mlk Ql Cult |
|
|
|
|
|
C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Listeriosis; Microbiology; Mlk; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; species; spp |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20871-0 |
Listeria sp |
PrThr |
Cheese |
Pt |
Ord |
Organism specific culture |
|
ACTIVE |
Listeria sp [Presence] in Cheese by Organism specific culture |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20871-0 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
Listeria Cheese Ql Cult |
|
|
|
|
|
C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Listeriosis; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; species; spp |
2.56 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
20872-8 |
Magnesium |
MCnc |
Ocular fld |
Pt |
Qn |
|
|
ACTIVE |
Magnesium [Mass/volume] in Ocular fluid |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
20872-8 |
|
|
|
|
Both |
|
|
|
0 |
Magnesium Ocflu-mCnc |
|
|
|
Y |
|
Chemistry; Eye fluid; Level; MAG; Magnes; Mass concentration; Mg; Occular fluid; Ocflu; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.42 |
1.0m |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
20873-6 |
Alcelaphine herpesvirus 1 Ab.Neut |
PrThr |
Ser |
Pt |
Ord |
Neut |
|
ACTIVE |
Alcelaphine herpesvirus 1 neutralizing antibody [Presence] in Serum by Neutralization test |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20873-6 |
|
Neut |
|
|
Both |
|
|
|
0 |
AHV1 NAb Ser Ql Nt |
|
|
|
|
|
ABS; Aby; AHV1; AlHV-1; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BMCF; Conventional virus neutralization test; cVNT; Herpes virus; i; ID; Infectious Disease; InfectiousDisease; Malignant catarrhal fever; Microbiology; NAb; NEUTRALIZATION; Neutralization test; NT; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; Serum virus neutralization; SR; SVN; Vet; Veterinary; Virus neutralization test; VNT |
2.72 |
1.0m |
|
|
|
|
|
|
|
|
|
|
Release 2.72: COMPONENT: Updated "Ab" to "Ab.Neut" since this test is detecting neutralizing antibodies.; Previous Releases: The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |